Previous 10 | Next 10 |
ROSELAND, N.J., May 16, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery systems that provide painless and precise injections, today announced that it has commenced sales of CompuFlo ® Epidural disposables ...
2023-05-11 13:25:06 ET Milestone Scientific Inc. (MLSS) Q1 2023 Earnings Conference Call May 10, 2023 8:30 AM ET Company Participants David Waldman – Investor Relations Arjan Haverhals – Chief Executive Officer Peter Milligan – Chief Financia...
2023-05-11 07:03:38 ET Milestone Scientific press release ( NYSE: MLSS ): Q1 GAAP EPS of -$0.02 in-line. Revenue of $2.59M (-4.1% Y/Y) beats by $0.09M . For further details see: Milestone Scientific GAAP EPS of -$0.02 in-line, revenue of $2.59M beats by $0.09M
ROSELAND, N.J., May 11, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the first quarter ended Ma...
ROSELAND, N.J., May 10, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections, as well as AI-assisted medical technology, today announced the successful completion of the fir...
ROSELAND, N.J., May 09, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery systems that provide painless and precise injections, today announced that it has commenced sales of CompuFlo ® Epidural disposables i...
ROSELAND, N.J., May 05, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Thursday, May 11,...
2023-03-31 19:34:07 ET Milestone Scientific Inc. (MLSS) Q4 2022 Results Conference Call March 31, 2023 08:30 AM ET Company Participants David Waldman - Investor Relations Arjan Haverhals - Chief Executive Officer Peter Milligan - Chief Financial Officer of Milest...
2023-03-31 08:24:01 ET Milestone Scientific press release ( NYSE: MLSS ): FY GAAP EPS of -$0.12. Revenue of $8.81M (-14.5% Y/Y). For further details see: Milestone Scientific GAAP EPS of -$0.12, revenue of $8.81M
ROSELAND, N.J., March 31, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the year ending December...
News, Short Squeeze, Breakout and More Instantly...
Milestone Scientific Inc. Company Name:
MLSS Stock Symbol:
NYSE Market:
Milestone Scientific Inc. Website:
ROSELAND, N.J., July 10, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced at the Sixth Annual American Society of Pain & Neuroscience Conference in ...
Brazil is the 9th largest economy in the world with more than 21 million people suffering from chronic back pain An estimated 4-5 million epidural anesthesia procedures are performed annually in Brazil; potential to expand this addressable market due to CompuFlo’s technolog...
Sales through new online portal increase 31% over the same period last year Gross margin for the first quarter of 2024 increases to 74.5% from 72.7% for the same period last year Reports steady progress on reimbursement strategy for the CompuFlo® Epidural System ...